Feb 22, 2022
(OAKVILLE, Ontario) February 22, 2022 – FORUS Therapeutics, a Canadian biopharmaceutical company dedicated to advancing differentiated, novel medicines for hematologic malignancies and other forms of cancer, today announced it has secured $2.5M CAD in growth capital...
Feb 3, 2022
FORUS Therapeutics is delighted to introduce Marie-Josèphe Champagne as the Senior Medical Science Liaison for Québec and Atlantic Canada. Marie-Josèphe has over 18 years of experience in the pharmaceutical industry in commercial and medical affairs roles, primarily...
Recent Comments